185 related articles for article (PubMed ID: 9652533)
1. Dynamic MRI of the breast.
Ercolani P; Valeri G; Amici F
Eur J Radiol; 1998 May; 27 Suppl 2():S265-71. PubMed ID: 9652533
[TBL] [Abstract][Full Text] [Related]
2. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
4. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
5. A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions.
Perman WH; Heiberg EM; Grunz J; Herrmann VM; Janney CG
Magn Reson Imaging; 1994; 12(4):545-51. PubMed ID: 8057758
[TBL] [Abstract][Full Text] [Related]
6. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
7. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
8. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
10. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis.
Liu PF; Debatin JF; Caduff RF; Kacl G; Garzoli E; Krestin GP
Br J Radiol; 1998 May; 71(845):501-9. PubMed ID: 9691895
[TBL] [Abstract][Full Text] [Related]
11. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions.
den Boer JA; Hoenderop RK; Smink J; Dornseiffen G; Koch PW; Mulder JH; Slump CH; Volker ED; de Vos RA
J Magn Reson Imaging; 1997; 7(4):702-15. PubMed ID: 9243392
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
14. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging of breast tumors at 3 and 7 T: a comparison.
Gruber S; Pinker K; Zaric O; Minarikova L; Chmelik M; Baltzer P; Boubela RN; Helbich T; Bogner W; Trattnig S
Invest Radiol; 2014 May; 49(5):354-62. PubMed ID: 24619208
[TBL] [Abstract][Full Text] [Related]
16. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.
Kaiser WA; Zeitler E
Radiology; 1989 Mar; 170(3 Pt 1):681-6. PubMed ID: 2916021
[TBL] [Abstract][Full Text] [Related]
18. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
19. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging.
Kvistad KA; Lundgren S; Fjøsne HE; Smenes E; Smethurst HB; Haraldseth O
Acta Radiol; 1999 Jan; 40(1):45-51. PubMed ID: 9973902
[TBL] [Abstract][Full Text] [Related]
20. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging.
Soyer P; de Givry SC; Gueye C; Lenormand S; Somveille E; Scherrer A
AJR Am J Roentgenol; 1996 May; 166(5):1115-21. PubMed ID: 8615254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
